Back
Monopar Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison
Sell
39
MNPR
Monopar Therapeutics
Last Price:
0.61
Seasonality Move:
-11.47%
Buy
52
CATX
Perspective Therapeutics
Last Price:
1.60
Seasonality Move:
2.9%
Sell
39
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
- The current Monopar Therapeutics [MNPR] share price is $0.61. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.60. The Score for CATX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $0.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.60
The current trend is moderately bearish and CATX is experiencing slight buying pressure.
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 41.64 | Sell |
Chaikin Money Flow: | -12021 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.62 - 0.72) | Sell |
Bollinger Bands (100): | (0.39 - 0.83) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 49.16 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.53 - 1.77) | Sell |
Bollinger Bands (100): | (0.67 - 1.53) | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.66 | Sell |
20-day SMA: | 0.67 | Sell |
50-day SMA: | 0.69 | Sell |
200-day SMA: | 0.56 | Buy |
8-day EMA: | 0.65 | Sell |
20-day EMA: | 0.67 | Sell |
50-day EMA: | 0.67 | Sell |
200-day EMA: | 0.74 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.69 | Sell |
20-day SMA: | 1.69 | Sell |
50-day SMA: | 1.47 | Buy |
200-day SMA: | 0.71 | Buy |
8-day EMA: | 1.66 | Sell |
20-day EMA: | 1.65 | Sell |
50-day EMA: | 1.46 | Buy |
200-day EMA: | 0.91 | Buy |
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.01 per share, an increase this year of $0.31 per share, and an increase next year of $0.02 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |